Literature DB >> 16182986

Emergency management of agitation in schizophrenia.

Catherine A Marco1, Jason Vaughan.   

Abstract

Schizophrenia is a common psychiatric condition, affecting approximately 1% of the population. Acute emergent presentations often include hallucinations, delusions, thought, and speech disorders. Agitation is common among emergency patients with schizophrenia. Decisional capacity should be assessed in all patients. Reversible causes of agitation should be ruled out, including infection, metabolic disorders, endocrine disorders, trauma, pain, noncompliance, toxicological disorders, and structural brain abnormalities. Agitation may be managed acutely using a combination of pharmacological agents and nonpharmacological interventions. Effective pharmacological agents include several classes of antipsychotic agents and benzodiazepines. Potential life-threatening complications of pharmacological therapy should be anticipated, which may include neuroleptic malignant syndrome (NMS), prolonged QT syndrome, and respiratory depression. Nonpharmacological interventions may include a quiet environment, physical restraints, and behavioral interventions. Disposition decisions should be made based on the etiology of agitation, effective management, decisional capacity, and presence of suicidal or homicidal intentions. Many patients who have required nonpharmacological or pharmacological management of agitation require inpatient psychiatric treatment, either voluntarily or involuntarily. Psychiatric consultation should be sought for patients with schizophrenia and uncertain disposition determinations, or those requiring other complex management decisions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182986     DOI: 10.1016/j.ajem.2005.02.050

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  20 in total

Review 1.  [Pharmacotherapy of psychiatric acute and emergency situations: General principles].

Authors:  T Messer; F-G Pajonk; M J Müller
Journal:  Nervenarzt       Date:  2015-09       Impact factor: 1.214

Review 2.  [The situation of emergency psychiatry in Germany].

Authors:  F-G B Pajonk
Journal:  Nervenarzt       Date:  2015-09       Impact factor: 1.214

Review 3.  Pharmacological control of acute agitation: focus on intramuscular preparations.

Authors:  Dan L Zimbroff
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.

Authors:  M M Cox; A M Tucker; J Tang; K Talbot; D C Richer; L Yeh; S E Arnold
Journal:  Genes Brain Behav       Date:  2009-02-11       Impact factor: 3.449

5.  A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation.

Authors:  Theodore D Satterthwaite; Daniel H Wolf; Robert A Rosenheck; Raquel E Gur; Stanley N Caroff
Journal:  J Clin Psychiatry       Date:  2008-12-02       Impact factor: 4.384

6.  Prescribing preferences in rapid tranquillisation: a survey in Belgian psychiatrists and emergency physicians.

Authors:  Chris Bervoets; Ella Roelant; Jürgen De Fruyt; Hella Demunter; Barry Dekeyser; Leen Vandenbussche; Koen Titeca; Guido Pieters; Bernard Sabbe; Manuel Morrens
Journal:  BMC Res Notes       Date:  2015-06-05

7.  Association between Medication Adherence and Duration of Outpatient Treatment in Patients with Schizophrenia.

Authors:  Seiichiro Tarutani; Hiroki Kikuyama; Munehiro Ohta; Tetsufumi Kanazawa; Takehiko Okamura; Hiroshi Yoneda
Journal:  Psychiatry Investig       Date:  2016-07-25       Impact factor: 2.505

8.  State of Acute Agitation at Psychiatric Emergencies in Europe: The STAGE Study.

Authors:  Luis San; Josef Marksteiner; Peter Zwanzger; María Aragüés Figuero; Francisco Toledo Romero; Grigorios Kyropoulos; Alberto Bessa Peixoto; Roxana Chirita; Anca Boldeanu
Journal:  Clin Pract Epidemiol Ment Health       Date:  2016-10-27

9.  Comparison of haloperidol and midazolam in restless management of patients referred to the Emergency Department: A double-blinded, randomized clinical trial.

Authors:  Mehrdad Esmailian; Omid Ahmadi; Mehrsa Taheri; Majid Zamani
Journal:  J Res Med Sci       Date:  2015-09       Impact factor: 1.852

10.  Use of antipsychotics and benzodiazepines in patients with psychiatric emergencies: results of an observational trial.

Authors:  Stefan Wilhelm; Alexander Schacht; Thomas Wagner
Journal:  BMC Psychiatry       Date:  2008-07-22       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.